News Updates
More Articles
- The Observatory of Good Regulatory Practices in the Regulation of Pharmaceutical Products: A Pioneering Initiative in Latin America
- Operational Excellence in an International Clinical Research Site Network
- Advancing the Implementation of ICH E17: Collaborative Efforts Driving Simultaneous Global Drug Development in China
- How to Build Partnerships for Sustainable Healthcare
- eCTD v4.0: A Look at 2025 and Beyond
Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
In response to collective calls to action, Patient Focused Medicines Development (PFMD) built upon previous collaborative work with the National Health Council (NHC) and the Workgroup of European Cancer Patient Advocacy Networks (WECAN) to outline practical solutions that support PE partners in navigating remuneration and in effectively applying fair market value (FMV) rates.
×
